These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 31548004

  • 1. GLP-1 and PYY3-36 reduce high-fat food preference additively after Roux-en-Y gastric bypass in diet-induced obese rats.
    Dischinger U, Corteville C, Otto C, Fassnacht M, Seyfried F, Hankir MK.
    Surg Obes Relat Dis; 2019 Sep; 15(9):1483-1492. PubMed ID: 31548004
    [Abstract] [Full Text] [Related]

  • 2. Toward a Medical Gastric Bypass: Chronic Feeding Studies With Liraglutide + PYY3-36 Combination Therapy in Diet-Induced Obese Rats.
    Dischinger U, Hasinger J, Königsrainer M, Corteville C, Otto C, Fassnacht M, Hankir M, Seyfried FJD.
    Front Endocrinol (Lausanne); 2020 Sep; 11():598843. PubMed ID: 33551994
    [Abstract] [Full Text] [Related]

  • 3. Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery.
    Svane MS, Jørgensen NB, Bojsen-Møller KN, Dirksen C, Nielsen S, Kristiansen VB, Toräng S, Wewer Albrechtsen NJ, Rehfeld JF, Hartmann B, Madsbad S, Holst JJ.
    Int J Obes (Lond); 2016 Nov; 40(11):1699-1706. PubMed ID: 27434221
    [Abstract] [Full Text] [Related]

  • 4. Rapid and body weight-independent improvement of endothelial and high-density lipoprotein function after Roux-en-Y gastric bypass: role of glucagon-like peptide-1.
    Osto E, Doytcheva P, Corteville C, Bueter M, Dörig C, Stivala S, Buhmann H, Colin S, Rohrer L, Hasballa R, Tailleux A, Wolfrum C, Tona F, Manz J, Vetter D, Spliethoff K, Vanhoutte PM, Landmesser U, Pattou F, Staels B, Matter CM, Lutz TA, Lüscher TF.
    Circulation; 2015 Mar 10; 131(10):871-81. PubMed ID: 25673670
    [Abstract] [Full Text] [Related]

  • 5. Peptide Tyrosine-Tyrosine Triggers GLP-2-Mediated Intestinal Hypertrophy After Roux-en-Y Gastric Bypass.
    Pérez-Arana GM, Díaz-Gómez A, Camacho-Ramírez A, Ribelles-García A, Almorza-Gomar D, Gracia-Romero M, Prada-Oliveira JA.
    Obes Surg; 2022 Dec 10; 32(12):4023-4032. PubMed ID: 36301409
    [Abstract] [Full Text] [Related]

  • 6. Exogenous peptide YY3-36 and Exendin-4 further decrease food intake, whereas octreotide increases food intake in rats after Roux-en-Y gastric bypass.
    Fenske WK, Bueter M, Miras AD, Ghatei MA, Bloom SR, le Roux CW.
    Int J Obes (Lond); 2012 Mar 10; 36(3):379-84. PubMed ID: 21694700
    [Abstract] [Full Text] [Related]

  • 7. Acute peripheral GLP-1 receptor agonism or antagonism does not alter energy expenditure in rats after Roux-en-Y gastric bypass.
    Abegg K, Schiesser M, Lutz TA, Bueter M.
    Physiol Behav; 2013 Sep 10; 121():70-8. PubMed ID: 23562866
    [Abstract] [Full Text] [Related]

  • 8. Roux-en-Y Gastric Bypass and Caloric Restriction but Not Gut Hormone-Based Treatments Profoundly Impact the Hypothalamic Transcriptome in Obese Rats.
    Dischinger U, Heckel T, Bischler T, Hasinger J, Königsrainer M, Schmitt-Böhrer A, Otto C, Fassnacht M, Seyfried F, Hankir MK.
    Nutrients; 2021 Dec 28; 14(1):. PubMed ID: 35010991
    [Abstract] [Full Text] [Related]

  • 9. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
    Bojsen-Møller KN.
    Dan Med J; 2015 Apr 28; 62(4):B5057. PubMed ID: 25872541
    [Abstract] [Full Text] [Related]

  • 10. Peripheral, but not central, GLP-1 receptor signaling is required for improvement in glucose tolerance after Roux-en-Y gastric bypass in mice.
    Carmody JS, Muñoz R, Yin H, Kaplan LM.
    Am J Physiol Endocrinol Metab; 2016 May 15; 310(10):E855-61. PubMed ID: 27026085
    [Abstract] [Full Text] [Related]

  • 11. Preoperative assessment of gut hormones does not correlate to weight loss after Roux-en-Y gastric bypass surgery.
    Werling M, Fändriks L, Vincent RP, Cross GF, le Roux CW, Olbers T.
    Surg Obes Relat Dis; 2014 May 15; 10(5):822-8. PubMed ID: 25282191
    [Abstract] [Full Text] [Related]

  • 12. Peptide YY and glucagon-like peptide-1 in morbidly obese patients before and after surgically induced weight loss.
    Reinehr T, Roth CL, Schernthaner GH, Kopp HP, Kriwanek S, Schernthaner G.
    Obes Surg; 2007 Dec 15; 17(12):1571-7. PubMed ID: 18046613
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. GLP-1 receptor signaling is not required for reduced body weight after RYGB in rodents.
    Ye J, Hao Z, Mumphrey MB, Townsend RL, Patterson LM, Stylopoulos N, Münzberg H, Morrison CD, Drucker DJ, Berthoud HR.
    Am J Physiol Regul Integr Comp Physiol; 2014 Mar 01; 306(5):R352-62. PubMed ID: 24430883
    [Abstract] [Full Text] [Related]

  • 15. Mechanisms of glucose homeostasis after Roux-en-Y gastric bypass surgery in the obese, insulin-resistant Zucker rat.
    Meirelles K, Ahmed T, Culnan DM, Lynch CJ, Lang CH, Cooney RN.
    Ann Surg; 2009 Feb 01; 249(2):277-85. PubMed ID: 19212182
    [Abstract] [Full Text] [Related]

  • 16. Meal patterns, satiety, and food choice in a rat model of Roux-en-Y gastric bypass surgery.
    Zheng H, Shin AC, Lenard NR, Townsend RL, Patterson LM, Sigalet DL, Berthoud HR.
    Am J Physiol Regul Integr Comp Physiol; 2009 Nov 01; 297(5):R1273-82. PubMed ID: 19726714
    [Abstract] [Full Text] [Related]

  • 17. Longitudinal assessment of food intake, fecal energy loss, and energy expenditure after Roux-en-Y gastric bypass surgery in high-fat-fed obese rats.
    Shin AC, Zheng H, Townsend RL, Patterson LM, Holmes GM, Berthoud HR.
    Obes Surg; 2013 Apr 01; 23(4):531-40. PubMed ID: 23269513
    [Abstract] [Full Text] [Related]

  • 18. Gut hypertrophy after gastric bypass is associated with increased glucagon-like peptide 2 and intestinal crypt cell proliferation.
    le Roux CW, Borg C, Wallis K, Vincent RP, Bueter M, Goodlad R, Ghatei MA, Patel A, Bloom SR, Aylwin SJ.
    Ann Surg; 2010 Jul 01; 252(1):50-6. PubMed ID: 20562614
    [Abstract] [Full Text] [Related]

  • 19. Effects of Manipulating Circulating Bile Acid Concentrations on Postprandial GLP-1 Secretion and Glucose Metabolism After Roux-en-Y Gastric Bypass.
    Jonsson I, Bojsen-Møller KN, Kristiansen VB, Veedfald S, Wewer Albrechtsen NJ, Clausen TR, Kuhre RE, Rehfeld JF, Holst JJ, Madsbad S, Svane MS.
    Front Endocrinol (Lausanne); 2021 Jul 01; 12():681116. PubMed ID: 34084153
    [Abstract] [Full Text] [Related]

  • 20. Weight loss in adult male Wistar rats by Roux-en-Y gastric bypass is primarily explained by caloric intake reduction and presurgery body weight.
    Hoornenborg CW, Somogyi E, Bruggink JE, Boyle CN, Lutz TA, Emous M, van Beek AP, Nyakas C, van Dijk G.
    Am J Physiol Regul Integr Comp Physiol; 2024 Jun 01; 326(6):R507-R514. PubMed ID: 38586888
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.